• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MR 引导下前列腺局灶激光消融治疗后肿瘤覆盖范围的评估。

Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy.

机构信息

Department of Biomedical Engineering, Western University, London, ON, N6A 3K7, Canada.

Robarts Research Institute, Western University, London, ON, N6A 5B7, Canada.

出版信息

Med Phys. 2019 Feb;46(2):800-810. doi: 10.1002/mp.13292. Epub 2018 Dec 7.

DOI:10.1002/mp.13292
PMID:30447155
Abstract

PURPOSE

Prostate cancer is the most common noncutaneous cancer among men in the USA. Focal laser thermal ablation (FLA) has the potential to control small tumors while preserving urinary and erectile function by leaving the neurovascular bundles and urethral sphincters intact. Accurate needle guidance is critical to the success of FLA. Multiparametric magnetic resonance images (mpMRI) can be used to identify targets, guide needles, and assess treatment outcomes. In this study, we evaluated the location of ablation zones relative to targeted lesions in 23 patients who underwent FLA therapy in a phase II trial. The ablation zone margins and unablated tumor volume were measured to determine whether complete coverage of each tumor was achieved, which would be considered a clinically successful ablation.

METHODS

Preoperative mpMRI was acquired for each patient 2-3 months preceding the procedure and the prostate and lesion(s) were manually contoured on 3 T T2-weighted axial images. The prostate and ablation zone(s) were also manually contoured on postablation 1.5 T T1-weighted contrast-enhanced axial images acquired immediately after the procedure intraoperatively. The lesion surface was nonrigidly registered to the postablation image using an initial affine registration followed by nonrigid thin-plate spline registration of the prostate surfaces. The margins between the registered lesion and ablation zone were calculated using a uniform spherical distribution of rays, and the volume of intersection was also calculated. Each prostate was contoured five times to determine the segmentation variability and its effect on intersection of the lesion and ablation zone.

RESULTS

Our study showed that the boundaries of the segmented tumor and ablation zone were close. Of the 23 lesions that were analyzed, 11 were completely covered by the ablation zone and 12 were partially covered. A shift of 1.0, 2.0, and 2.6 mm would result in 19, 21, and all tumors completely covered by the ablation zone, respectively. The median unablated tumor volume across all tumors was 0.1  with an IQR of 3.7  , which was 0.2% of the median tumor volume (46.5  with an IQR of 46.3  ). The median extension of the tumors beyond the ablation zone, in cases which were partially ablated, was 0.9 mm (IQR of 1.3 mm), with the furthest tumor extending 2.6 mm.

CONCLUSION

In all cases, the boundary of the tumor was close to the boundary of the ablation zone, and in some cases, the boundary of the ablation zone did not completely enclose the tumor. Our results suggest that some of the ablations were not clinically successful and that there is a need for more accurate needle tracking and guidance methods. Limitations of the study include errors in the registration and segmentation methods used as well as different voxel sizes and contrast between the registered T2 and T1 MRI sequences and asymmetric swelling of the prostate postprocedurally.

摘要

目的

前列腺癌是美国男性中最常见的非皮肤癌。局灶性激光热消融(FLA)有可能在保留神经血管束和尿道括约肌完整的情况下控制小肿瘤,同时保留尿和勃起功能。准确的针引导对 FLA 的成功至关重要。多参数磁共振成像(mpMRI)可用于识别目标、引导针并评估治疗结果。在这项研究中,我们评估了 23 名接受 FLA 治疗的患者的消融区相对于靶向病变的位置,这些患者参加了一项 II 期试验。测量了消融区边缘和未消融肿瘤的体积,以确定是否实现了对每个肿瘤的完全覆盖,这将被认为是一次临床成功的消融。

方法

每位患者在术前 2-3 个月接受了术前 mpMRI,并在 3T T2 加权轴向图像上手动勾画前列腺和病变。在手术中立即进行术后 1.5T T1 加权增强轴向图像后,还手动勾画了前列腺和消融区。使用初始仿射配准和前列腺表面的非刚性薄板样条配准,将病变表面非刚性地配准到术后图像上。使用射线的均匀球形分布计算注册病变和消融区之间的边界,并计算相交的体积。对每个前列腺进行五次轮廓勾画,以确定勾画的可变性及其对病变和消融区相交的影响。

结果

我们的研究表明,分割的肿瘤和消融区的边界是接近的。在分析的 23 个病变中,有 11 个完全被消融区覆盖,12 个部分被覆盖。如果针移动 1.0、2.0 和 2.6mm,则分别会有 19、21 和所有肿瘤完全被消融区覆盖。所有肿瘤的未消融肿瘤体积中位数为 0.1,IQR 为 3.7,占肿瘤体积中位数的 0.2%(46.5,IQR 为 46.3)。在部分消融的病例中,肿瘤超出消融区的延伸中位数为 0.9mm(IQR 为 1.3mm),最远的肿瘤延伸 2.6mm。

结论

在所有情况下,肿瘤边界都接近消融区边界,在某些情况下,消融区边界并没有完全包围肿瘤。我们的结果表明,有些消融并不完全成功,需要更准确的针跟踪和引导方法。研究的局限性包括所使用的配准和分割方法的误差,以及注册的 T2 和 T1 MRI 序列之间的不同体素大小和对比度以及前列腺术后的不对称肿胀。

相似文献

1
Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy.MR 引导下前列腺局灶激光消融治疗后肿瘤覆盖范围的评估。
Med Phys. 2019 Feb;46(2):800-810. doi: 10.1002/mp.13292. Epub 2018 Dec 7.
2
Toward mechatronic MRI-guided focal laser ablation of the prostate: Robust registration for improved needle delivery.迈向用于前列腺的机电一体化磁共振成像引导聚焦激光消融:用于改进针递送的稳健配准。
Med Phys. 2023 Mar;50(3):1259-1273. doi: 10.1002/mp.16190. Epub 2023 Jan 19.
3
Design and validation of an MRI-compatible mechatronic system for needle delivery to localized prostate cancer.设计并验证一种用于将针递送到局部前列腺癌部位的 MRI 兼容机电系统。
Med Phys. 2021 Sep;48(9):5283-5299. doi: 10.1002/mp.15050. Epub 2021 Jul 21.
4
T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy.T2*-加权 MRI 作为一种非增强对比方法,用于评估前列腺癌热疗中聚焦激光消融区域的范围。
Eur Radiol. 2021 Jan;31(1):325-332. doi: 10.1007/s00330-020-07127-7. Epub 2020 Aug 12.
5
Evaluation of Focal Laser Ablation of Prostate Cancer Using High Spectral and Spatial Resolution Imaging: A Pilot Study.高光谱和空间分辨率成像在前列腺癌激光消融治疗中的评价:一项初步研究。
J Magn Reson Imaging. 2019 May;49(5):1374-1380. doi: 10.1002/jmri.26538. Epub 2018 Oct 6.
6
Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.迈向磁共振成像前列腺癌轮廓勾画指南:通过精确组织学融合实现主要病灶大体和临床靶区覆盖
Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):188-96. doi: 10.1016/j.ijrobp.2016.04.018. Epub 2016 Apr 21.
7
MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging.磁共振成像引导下聚焦激光消融治疗前列腺癌后行根治性前列腺切除术:治疗效果与影像学的相关性
World J Urol. 2017 May;35(5):703-711. doi: 10.1007/s00345-016-1924-1. Epub 2016 Aug 19.
8
MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer.MRI 引导下前列腺癌聚焦激光消融治疗后的 MRI 表现。
AJR Am J Roentgenol. 2018 Sep;211(3):595-604. doi: 10.2214/AJR.17.19201. Epub 2018 Jul 11.
9
Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.前列腺癌的聚焦激光烧蚀:I 期临床试验。
J Urol. 2016 Jul;196(1):68-75. doi: 10.1016/j.juro.2015.12.083. Epub 2015 Dec 31.
10
Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.磁共振引导前列腺癌聚焦激光消融术的 II 期评估。
J Urol. 2016 Dec;196(6):1670-1675. doi: 10.1016/j.juro.2016.07.074. Epub 2016 Jul 20.

引用本文的文献

1
Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy.消融联合免疫治疗的临床应用现状与展望。
Front Immunol. 2022 Sep 5;13:965120. doi: 10.3389/fimmu.2022.965120. eCollection 2022.
2
Preclinical evaluation of a clinical prototype transrectal diffuse optical tomography system for monitoring photothermal therapy of focal prostate cancer.临床原型经直肠漫散射光学断层成像系统用于监测局灶性前列腺癌光热治疗的临床前评估。
J Biomed Opt. 2022 Feb;27(2). doi: 10.1117/1.JBO.27.2.026001.